Intravenous formulation of secukinumab gets FDA approvalOctober 10, 2023Psoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitis
FDA approves topical roflumilast for psoriasis in children aged 6-11October 6, 2023PediatricsPsoriatic Arthritis
FDA approves ninth Humira biosimilar, with interchangeabilityOctober 6, 2023Rheumatoid ArthritisPsoriatic ArthritisPediatricsSpondyloarthropathiesAnkylosing spondylitis
Severe psoriasis linked to a higher risk for heart disease, study confirmsSeptember 21, 2023Psoriatic Arthritis
Medicare announces 10 drugs targeted for price cuts in 2026August 30, 2023Business of MedicinePsoriatic ArthritisRheumatoid Arthritis
Rheumatology trials seem vulnerable to unblinding: ReportAugust 28, 2023Rheumatoid ArthritisLupus & Connective Tissue DiseasesPsoriatic ArthritisAnkylosing spondylitis
Structural changes may separate axial psoriatic arthritis from axial spondyloarthritisAugust 22, 2023Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Could risk stratifying methotrexate users lead to less frequent testing?July 28, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
Humira biosimilars: Five things to knowJuly 19, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
